Dr. George Gittes’ Diabetes Gene Therapy Licensed to Genprex, Inc. Phase I Clinical Trial Next Step
Genprex, Inc., a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases, today [...]